Pediatric Oncology

Neuroblastoma

Questions discussed in this category

Would you use autologous hematopoietic stem cells collected from a HR neuroblastoma patient found to be COVID positive after harvest?

Both the patient's nasopharyngeal swab and stem cells themselves resulted COVID positive post-harvesting.

1 Answer available

What modality (urine catecholamines, PET, MIBG) is the most sensitive for evaluation of treatment response in a patient with high-risk neuroblastoma?

1 Answer available

Papers discussed in this category

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017-08-01

Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting.

Lancet Haematol, 2021 Feb 01

Allogeneic haematopoietic stem cell transplantation from SARS-CoV-2 positive donors.

Transfusion, 2020 May 27

SARS-CoV-2 asymptomatic and symptomatic patients and risk for transfusion transmission.

Vox Sang, 2020 Apr 21

Post-donation COVID-19 identification in blood donors.

Lancet, 2020 Feb 12

Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records.

Related Topics in Pediatric Oncology